Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1143studies shown

Showing 721-732 of 1,143

Drug study icon

TerminatedNCT01520350

Low-Dose Adjunctive Aripiprazole in the Treatment of Depression for depression in bipolarity

This study was terminated in Canada. It is testing Low-Dose Adjunctive Aripiprazole in the Treatment of Depression for depression in bipolarity.

In Canada

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Serge Beaulieu
Condition: Bipolarity, Depression

Drug study icon

UnknownNCT02167048

Low-dose vs. Normal-dose Psychostimulants on Executive Functions in Individuals With ADHD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHDDrugFrom 6 Years to 18 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: ADHD

Drug study icon

CompletedNCT00868959

Lurasidone - A 24-week Extension Study of people with Bipolar I Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, France, Canada, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT02147379

Lurasidone and Cognition in Bipolarity type I

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

BipolarityDrugFrom 19 Years to 65 Years

Countries: Canada
Sponsor: University of British Columbia
Condition: Bipolarity

Drug study icon

CompletedNCT01485640

Lurasidone Extended Use Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Schizophrenia, BipolarityDrug

Countries: France, Canada, Colombia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Schizophrenia, Bipolarity

Drug study icon

CompletedNCT01284517

Lurasidone HCI - A 6-week Phase 3 Study of people with Bipolar I Depression

This study is completed in the United States, in Canada, in Colombia, .... It focuses on depression.

In Canada

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Canada, Colombia, ...
Sponsor: Sumitomo Pharma America, Inc.
Condition: Bipolarity, Depression

Behavioral study icon

CompletedNCT01596608

Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and OCD

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Depression, Schizophrenia, ...BehavioralFrom 18 Years to 85 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression, Schizophrenia, ...

Behavioral study icon

CompletedNCT03361826

Magnetic Seizure Therapy for Borderline Personality Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SuicidalityBehavioralFrom 18 Years to 50 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Suicidality

Other study type icon

Enrolling By InvitationNCT06978881

Magnetoencephalography in Psychosis Program

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaObservationalFrom 18 Years to 50 Years

Countries: Canada
Sponsor: Douglas Mental Health University Institute
Condition: Schizophrenia

Drug study icon

CompletedNCT05339074

Maintenance Ketamine Infusions for Treatment-Resistant Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Bipolarity, DepressionDrugFrom 21 Years to 65 Years

Countries: Canada
Sponsor: Joshua Rosenblat
Condition: Bipolarity, Depression

Drug study icon

CompletedNCT01081145

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

ADHDDrugFrom 6 Years to 17 Years

Countries: United States, France, Canada, ...
Sponsor: Shire
Condition: ADHD

Behavioral study icon

CompletedNCT05702086

Making SPARX Fly in Nunavut: Testing an E-intervention for Boosting Resilience Against Youth Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionBehavioralFrom 13 Years to 18 Years

Countries: Canada
Sponsor: York University
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.